Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial.
Ann Oncol
; 32(12): 1590-1596, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34520831
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Triple Negative Breast Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2021
Type:
Article